Phase
Condition
Liver Transplantation
Renal Failure
Kidney Failure
Treatment
Albumin administration
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and female subjects equal or above 18 yrs old.
Recipients of primary liver allografts from a deceased donor (including aftercardiac death) and as a single organ (liver only).
Capability of understanding the purpose and risks of the study.
Written informed consent
Exclusion
Exclusion Criteria:
Fulminant hepatitis
Kidney injury at baseline (Estimated Glomerular Filtration Rate < 50 ml/min inModification of diet in renal disease-6) including hepatorenal syndrome
Use of an induction agent Basiliximab at liver transplantation
Protected person (adults legally protected, under judicial protection, guardianship,or supervision), person deprived of their liberty
At the time of randomisation, participation to another interventional study
Study Design
Connect with a study center
08_CHRU de Tours Hôpital Trousseau
Chambray-les-tours, 37170
FranceSite Not Available
03_APHP Hôpital Beaujon
Clichy, 92110
FranceSite Not Available
04_CHU de Lille Hôpital Huriez
Lille, 59000
FranceSite Not Available
05_HCL Hôpital de la Croix Rousse
Lyon, 69004
FranceSite Not Available
06_CHU de Montpellier Hôpital St Eloi
Montpellier, 34295
FranceSite Not Available
07_APHP Hôpital La Pitié Salpêtrière
Paris, 75651
FranceSite Not Available
02_CHU de Bordeaux - Hôpital Haut Leveque
Pessac, 33604
FranceSite Not Available
01_CHU de Rennes Hôpital Pontchaillou
Rennes, 35000
FranceActive - Recruiting
09_APHP Hôpital Paul Brousse
Villejuif, 94804
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.